1. Use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced risk of developing substance use disorders among US...
1. Prenatal depression and gestational diabetes were independently associated with a higher risk of childhood obesity within the first 10...
1. Glucagon-like peptide-1 receptor agonists (GLP-1RA) in combination with progestins are significantly more effective at reducing endometrial cancer (EC) risk...
1. Sleeve gastrectomy produces substantially greater and more durable weight loss than semaglutide over 12 months in patients with obesity....
1. In diabetes-free individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) and obesity, berberine is safe, well-tolerated, and associated with...
1. Nearly one in three people with cystic fibrosis experienced nephrolithiasis during their lifetime. 2. The degree of exocrine pancreatic...
1. Among pregnant patients at risk of preterm delivery, metformin was associated with lower mean maternal glucose values and a...
1. 12 weeks of aerobic–resistance training and high-intensity interval training improved metabolic, functional, and quality-of-life outcomes in adults with type...
1. Low-dose combined hormonal contraceptives managed symptoms of polycystic ovarian syndrome (PCOS) without increasing the prevalence of metabolic syndrome among...
1. In this systematic review and meta-analysis, use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) was not associated with a significant...
